Related Experiment Video
Updated: May 27, 2026
06:07
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
CD72 gene expression in immune thrombocytopenia.
Hu Zhou1, Ai-Ping Qi, Hui-Yuan Li
1State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Platelets
|November 25, 2011
Summary
CD72 mRNA expression is lower in active immune thrombocytopenia (ITP) patients, suggesting its role in ITP pathogenesis. This finding may help understand ITP disease mechanisms by increasing B-cell receptor signals.
Area of Science:
- Immunology
- Pathophysiology
Background:
- Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts.
- The role of CD72 in ITP pathogenesis is not well understood.
Purpose of the Study:
- To investigate the role of CD72 in the pathogenesis of immune thrombocytopenia (ITP).
Main Methods:
- Detected CD72, Sema4D, IL-2, IL-4, and IFN-γ mRNA expressions in ITP patients and controls.
- Measured plasma levels of Sema4D, IL-2, IL-4, IL-6, and IFN-γ using radioimmunoassay and ELISA.
- Analyzed mRNA expressions using real-time quantitative reverse-transcription polymerase chain reaction.
Main Results:
- CD72 mRNA expression was significantly lower in active ITP patients compared to those in remission and controls.
- IFN-γ/IL-4 mRNA (Th1/Th2) expression was significantly higher in active and remission ITP patients versus controls.
- IL-2 mRNA expression and plasma IL-2 levels were significantly lower in active ITP patients compared to controls and patients in remission.
- Plasma IL-4 levels were significantly higher in active and remission ITP patients versus controls.
- CD72 mRNA expression correlated with Sema4D mRNA and plasma IL-2 levels in active ITP patients.
Conclusions:
- CD72 may be involved in ITP pathogenesis by modulating B-cell receptor signaling.
- Altered cytokine profiles (IFN-γ, IL-4, IL-2) are associated with ITP.
- CD72 expression levels may serve as a potential biomarker in active ITP.
